Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Aditxt Inc

ADTX ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$0.01

▼ -77.22%

Market Cap $2.30M · Vol 132.23M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$2.30M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

23.38

Momentum

Beta

0.97

vs Market

52W High

$52,721.28

100.00% below

52W Low

$0.00

131.71% above

Volume

132.23M

Avg 60.12M

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

99.94%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Aditxt Inc (ADTX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ADTX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-12.84%

-98.15%

-99.96%

-100.00%

YTD

-99.99%

-100.00%

Financials & Valuation

TTM · Annual

Total Revenue	$3.20K
Net Income	$-42,787,040.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-175.86% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	997.98M

Technical Indicators

50-Day SMA	$3.07
200-Day SMA	$3,379.44
RSI (14)	23.38
Beta	0.97
52-Week High	$52,721.28
52-Week Low	$0.00

Volume Today	132.23M
Avg Daily Volume (30D)	60.12M
Relative Volume	2.20x
Volatility (10D)	1,111.41
Volatility (30D)	708.64
Free Float	99.94%

Analyst Consensus

N/A

Current Price $0.01

Mean Target N/A

52W Low$0.00 52W High$52,721.28

Current

Target

$0.00 $52,721.28

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00RDV1WT4

ISINUS0070258696

CountryUnited States of America

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Aditxt, Inc. is a social innovation platform accelerating promising health innovations. The Company operates four programs focused on autoimmunity, cancer and early disease detection, infectious diseases and women’s health. Its subsidiaries include Adimune, Inc. (Adimune), Pearsanta, Inc., Adivir, Inc. and Adifem, Inc. Adimune is focused on its immune modulation therapeutic programs. Adimune’s proprietary immune modulation product, Apoptotic DNA Immunotherapy (ADI), utilizes a novel approach that mimics the way its bodies naturally induce tolerance to our own tissues. Adivir, Inc. is focused on building a portfolio of antiviral and other antimicrobial solutions designed to target life-threatening viral infections and emerging pathogens. Pearsanta, Inc. is engaged in the development of molecular tests based on mitochondrial DNA to develop tests for early detection of cancer. It is also focused on addressing a critical challenge in cancer care: optimizing therapy selection.